ramipril and pyrogallol-sulfonphthalein

In the current study, we compared purified Salvia miltiorrhiza extract (PSME) with Angiotensin-converting enzyme inhibitor, Ramipril, in in vitro experiments and also in vivo using animal model of myocardial infarction. PSME was found to have a significantly higher trolox equivalent antioxidant capacity which indicated a great capacity for scavenging free radicals. PSME could also prevent pyrogallo red bleaching and DNA damage. After 2 weeks treatment with PSME or Ramipril, survival rates of rats with experimental myocardial infarction were marginally increased (68.2% and 71.4%) compared with saline (61.5%). The ratios of infarct size to left ventricular size in both PSME-and Ramipril-treated rats were significantly less than that in the saline-treated group. Activity of cardiac antioxidant enzyme superoxide dismutase (SOD) was significant higher while level of Thiobarbituric acid-reactive substances (TBARs) was lower in the PSME treated group. Purified and standardized Chinese herb could provide an alternative regimen for the prevention of ischemic heart disease.

Topics: Analysis of Variance; Animals; Antioxidants; Benzothiazoles; DNA Damage; Drugs, Chinese Herbal; Gas Chromatography-Mass Spectrometry; Male; Myocardial Infarction; Myocardial Ischemia; Phytotherapy; Pyrogallol; Ramipril; Rats; Rats, Wistar; Salvia miltiorrhiza; Spectrophotometry; Sulfonic Acids; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Ventricular Remodeling